Depression Clinical Trials in Philadelphia

Showing 141-160 of 232 trials

Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

NCT01913535

This study is looking at the efficacy, rapidity, safety, and tolerability of two doses of oral CERC-501 for treating patients with treatment resistant depression who are taking an antidepressant that is not working for them.

Treatment Resistant Depression

Massachusetts General Hospital8 participantsStarted Sep 2013

Chicago, Illinois, United States • Wichita, Kansas, United States • Philadelphia, Pennsylvania, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Treatments for Depression: Drug Versus Psychotherapy

NCT00043550

This 4-8 month study, with a 2-year follow up period, will compare sertraline (Zoloft®), venlafaxine (Effexor®), supportive-expressive psychotherapy, and placebo to determine which is more effective in treating major depression.

Depression

University of Pennsylvania156 participantsStarted Nov 2001

Philadelphia, Pennsylvania, United States

Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

Treatments for Depression: Drug Versus Psychotherapy

Depression Trials in Other Cities

Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication

Depression in Alzheimer's Disease-2

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Treatment for Depression Among HIV-Infected Youth

Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)

Lethargic Depression Study

Comparison of Depression Interventions After Acute Coronary Syndrome

Mental Health Services for Foster and Adopted Children

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

Sexual Functioning Study With Antidepressants

Depression and Health Outcomes in Refractory Epilepsy

Combination Treatment Study for Memory Impairment and Depression

Prolonging Remission in Depressed Elderly (PRIDE)

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Early Detection and Intervention for the Prevention of Psychosis

Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State

Systems of Support Study for Childhood Depression

Other Conditions in Philadelphia